Latest News and Press Releases
Want to stay updated on the latest news?
-
If you purchased or acquired SES AI Corporation securities between January 29, 2025 and March 4, 2026 and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker...
-
PORTLAND, Maine, June 25, 2026 (GLOBE NEWSWIRE) -- The Elmet Group Co. (Nasdaq: ELMT) (“Elmet” or the “Company”), a U.S.-based provider of precision-engineered components and advanced high-energy...
-
TARRYTOWN, N.Y., June 25, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2026 financial and operating results on...
-
NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- At the end of the settlement date of June 15, 2026, short interest in 3,764 Nasdaq Global Market℠ securities totaled 17,903,270,409 shares compared with...
-
MINNEAPOLIS, MN, US, June 25, 2026 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTCQX: PETV) (OTCID: PETVW), in cooperation with its wholly-owned subsidiaries, Cosmeta Corp, PetVivo Animal Health,...
-
TORONTO, June 25, 2026 (GLOBE NEWSWIRE) -- Base Carbon Inc. (Cboe CA: BCBN) (OTCQX: BCBNF) with operations through its wholly-owned subsidiary, Base Carbon Capital Partners Corp. (together, with...
-
Ligand Announces Closing of Convertible Senior Notes Offering
-
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by...
-
LEXINGTON, Mass., June 25, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and...
-
COPENHAGEN, Denmark, June 25, 2026 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the latest data from its clinical development programs for the treatment of children...